SLC1A2 and amyotrophic lateral sclerosis: Transgenic expression of EAAT2 (Guo et al., 2003) or treatment with the small compound LDN/OSU-0212320 (Kong et al., 2014), which mainly increases translation of EAAT2 mRNA, improves the motor performance of an ALS mouse model expressing hSOD1G93A.